Sébastien Bonnet

16.4k total citations · 3 hit papers
192 papers, 11.6k citations indexed

About

Sébastien Bonnet is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sébastien Bonnet has authored 192 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Pulmonary and Respiratory Medicine, 69 papers in Molecular Biology and 60 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sébastien Bonnet's work include Pulmonary Hypertension Research and Treatments (142 papers), Cardiovascular Function and Risk Factors (22 papers) and MicroRNA in disease regulation (20 papers). Sébastien Bonnet is often cited by papers focused on Pulmonary Hypertension Research and Treatments (142 papers), Cardiovascular Function and Risk Factors (22 papers) and MicroRNA in disease regulation (20 papers). Sébastien Bonnet collaborates with scholars based in Canada, United States and France. Sébastien Bonnet's co-authors include Steeve Provencher, Evangelos D. Michelakis, Roxane Paulin, Alois Haromy, Stephen L. Archer, Jolyane Meloche, Kyoko Hashimoto, Olivier Boucherat, François Potus and M. Sean McMurtry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Sébastien Bonnet

180 papers receiving 11.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

2007 1.2k citations Sébastien Bonnet, Stephen L. Archer et al. profile →
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

2018 837 citations Sébastien Bonnet, Peter Dorfmüller et al. profile →
Pathology and pathobiology of pulmonary hypertension: current insights and future directions

2024 43 citations Sébastien Bonnet, Peter Dorfmüller et al. profile →

Peers

Sébastien Bonnet

PRM

CCM

SURGE

Evangelos D. Michelakis Canada

Jason X.‐J. Yuan United States

Christophe Guignabert France

Serge Adnot France

Soni Savai Pullamsetti Germany

Alois Haromy Canada

Ralph T. Schermuly Germany

Harm Jan Bogaard Netherlands

Kyoko Hashimoto Japan

Yulin Liao China

Evangelos D. Michelakis Canada

Sébastien Bonnet

8.0k ×1.1

PRM

7.5k ×1.5

5.0k ×1.5

CCM

3.3k ×1.3

1.7k ×1.3

SURGE

Citations per year, relative to Sébastien Bonnet Sébastien Bonnet (= 1×) peers Evangelos D. Michelakis

Countries citing papers authored by Sébastien Bonnet

Since Specialization

Citations

This map shows the geographic impact of Sébastien Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Bonnet more than expected).

Fields of papers citing papers by Sébastien Bonnet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Bonnet. The network helps show where Sébastien Bonnet may publish in the future.

Co-authorship network of co-authors of Sébastien Bonnet

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Bonnet. A scholar is included among the top collaborators of Sébastien Bonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Bonnet. Sébastien Bonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martineau, Sandra, Grégoire Ruffenach, Malik Bisserier, et al.. (2026). Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension. Circulation. 153(7). 516–533.

Tian, Jinglin, Steeve Provencher, Sébastien Bonnet, et al.. (2025). Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges. Journal of Translational Medicine. 23(1). 1288–1288.

Cober, Nicholas D, Rafael Soares Godoy, Yupu Deng, et al.. (2025). Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension. Cardiovascular Research. 121(13). 2095–2112. 2 indexed citations

Xia, Lu, Olivier Boucherat, Karthik Suresh, et al.. (2024). Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation Heart Failure. 17(11). e012067–e012067. 2 indexed citations

Yokokawa, Tetsuro, Olivier Boucherat, Sandra Martineau, et al.. (2024). Prognostic Significance of Proteomics‐Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension. Journal of the American Heart Association. 13(12). e032888–e032888. 6 indexed citations

Mendes‐Ferreira, Pedro, Rui Adão, Steeve Provencher, et al.. (2024). Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function. International Journal of Molecular Sciences. 25(15). 8054–8054. 4 indexed citations

Provencher, Steeve, et al.. (2023). The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets. Vascular Pharmacology. 151. 107180–107180. 2 indexed citations

Bisserier, Malik, et al.. (2022). Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent Models. Methods in molecular biology. 2573. 263–278. 1 indexed citations

Sommer, Natascha, Hossein Ardeschir Ghofrani, Oleg Pak, et al.. (2020). Current and future treatments of pulmonary arterial hypertension. British Journal of Pharmacology. 178(1). 6–30. 118 indexed citations

10.

Maron, Bradley A., Mark T. Gladwin, Sébastien Bonnet, et al.. (2020). Perspectives on Cardiopulmonary Critical Care for Patients With COVID‐19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Journal of the American Heart Association. 9(14). e017111–e017111. 4 indexed citations

11.

Nickel, Nils, Ke Yuan, Peter Dorfmüller, et al.. (2019). Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 201(2). 148–157. 57 indexed citations

12.

Kuebler, Wolfgang M., Sébastien Bonnet, & Arata Tabuchi. (2018). Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series). Pulmonary Circulation. 8(2). 1–13. 41 indexed citations

13.

Frump, Andrea L., Sébastien Bonnet, Vinicio A. de Jesús Pérez, & Tim Lahm. (2018). Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension. PMC.

14.

Frump, Andrea L., Bakhtiyor Yakubov, Mary Beth Brown, et al.. (2016). Abstract 20654: An Estrogen Receptor α (ERα)-BMPR2-Apelin Axis Mediates 17β-Estradiol’s Protective Effects on Right Ventricular Function in Experimental Pulmonary Hypertension (PH). Circulation. 134. 1 indexed citations

15.

Meloche, Jolyane, François Potus, Benoît Ranchoux, et al.. (2015). miR-223 reverses experimental pulmonary arterial hypertension. American Journal of Physiology-Cell Physiology. 309(6). C363–C372. 102 indexed citations

16.

Potus, François, Grégoire Ruffenach, Abdellaziz Dahou, et al.. (2015). Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. 132(10). 932–943. 168 indexed citations

17.

Meloche, Jolyane, Aude Pflieger, Mylène Vaillancourt, et al.. (2013). Role for DNA Damage Signaling in Pulmonary Arterial Hypertension. Circulation. 129(7). 786–797. 198 indexed citations

18.

Bonnet, Sébastien, Gaël Y. Rochefort, Gopinath Sutendra, et al.. (2007). The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proceedings of the National Academy of Sciences. 104(27). 11418–11423. 298 indexed citations

19.

Archer, Stephen L., Evangelos D. Michelakis, Bernard Thébaud, et al.. (2006). A Central Role for Oxygen‐Sensitive K ⁺ Channels and Mitochondria in the Specialized Oxygen‐Sensing System. Novartis Foundation symposium. 272. 157–175. 22 indexed citations

20.

Bonnet, Sébastien, et al.. (2005). Sildenafil Improves Alveolar Growth and Pulmonary Hypertension in Hyperoxia-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 172(6). 750–756. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact